Cognitive Effects of Cancer and Its Treatments at the Intersection of Aging: What Do We Know; What Do We Need to Know?
- 1 December 2013
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 40 (6) , 709-725
Abstract
No abstract availableKeywords
This publication has 175 references indexed in Scilit:
- Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trialThe Lancet, 2013
- Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivorsBrain, Behavior, and Immunity, 2013
- Prefrontal Cortex and Executive Function Impairments in Primary Breast CancerArchives of Neurology, 2011
- Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI studyBreast Cancer Research and Treatment, 2010
- Alterations in brain antioxidant enzymes and redox proteomic identification of oxidized brain proteins induced by the anti-cancer drug adriamycin: implications for oxidative stress-mediated chemobrainNeuroscience, 2010
- The effect of modafinil on cognitive function in breast cancer survivorsCancer, 2009
- Aging of cerebral white matter: a review of MRI findingsInternational Journal of Geriatric Psychiatry, 2008
- Cognitive function in breast cancer patients prior to adjuvant treatmentBreast Cancer Research and Treatment, 2007
- Candidate mechanisms for chemotherapy-induced cognitive changesNature Reviews Cancer, 2007
- Cognitive‐behavioral management of chemotherapy‐related cognitive changePsycho-Oncology, 2006